Cordis Pipeline Includes Stents, A-Fib Ablation, Percutaneous AAA Repair

Cordis will file a PMA in 2011 for its Nevo drug-eluting, cobalt chromium coronary stent with reservoir-based delivery technology gained through the 2007 acquisition of Conor Medsystems, the Johnson & Johnson subsidiary says

More from Archive

More from Medtech Insight